Literature DB >> 2324559

Subarachnoid and epidural calcitonin in patients with pain due to metastatic cancer.

J Blanchard, E Menk, S Ramamurthy, J Hoffman.   

Abstract

Nine patients with metastatic cancer who had pain refractory to traditional treatments received a subarachnoid injection of salmon calcitonin. Eight of the nine patients reported pain relief after subarachnoid injection varying from 1 hr to 5 days. Four of the responding patients subsequently received an epidural injection of salmon calcitonin, and two of these patients reported pain relief. Although many patients experienced pain relief, nausea and vomiting appeared to be a significant side effect, occurring in seven out of nine patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324559     DOI: 10.1016/s0885-3924(05)80008-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  [Not Available].

Authors:  M Tryba
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

2.  Effects of calcitonin on human auditory and visual evoked brain potentials.

Authors:  R Pietrowsky; M Dentler; H L Fehm; J Born
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases.

Authors:  V Kovcin; S Jelić; N Babović; Z Tomasević
Journal:  Support Care Cancer       Date:  1994-01       Impact factor: 3.603

Review 4.  Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Authors:  P C Braga
Journal:  Agents Actions       Date:  1994-05

5.  [Intrathecal and epidural administration of non-opioid analgesics in acute and chronic pain treatment.].

Authors:  B Donner; M Tryba; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.